top of page

Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Management of Obesity

​

This article looks at the effectiveness of GLP-1 receptor agonists for weight loss as a primary or secondary treatment outcome.

 

As a class, GLP-1 receptor agonists have a generally more favourable safety profile than several other antiobesity agents; transient, mild-to-moderate gastrointestinal symptoms were the most frequently reported adverse effects in clinical trials.

 

Read the full article below.

  • Black Facebook Icon
  • Black Instagram Icon
trustpilot1.png
1000_PenCycle_Logo.png
ICO-registered_edited.jpg

Protecting your data

Enter your email address to receive updates

Thanks for submitting!

Contact Us  | Articles

Returns Policy | Delivery Policy | Privacy Policy

Medicines Risk Policy Complaints 

My Rewards | My AccountSupport Hub

​

Want to try non-medicated weight loss?

Try the NHS 12 Week Plan​​​

​

Our operating hours are:

Mon-Fri 9am - 7pm

Sat-Sun 10am - 4pm

Please note that we may email you outside of these hours.

​

Slim Transformation is not an online pharmacy nor do we dispense medications - we are an intermediary platform between patient, prescriber and dispensing pharmacy. Your information is reviewed by a UK regulated prescriber. If approved, your prescription is then dispensed by a UK registered & regulated pharmacy. Slim Transformation will provide you with aftercare, meal plans, exercise plans & ongoing support in conjunction with advice from our pharmacy partners.

​

Our pharmacy partners are:

Archer Pharmacy (GPhC Registration: 9010261)

Acre Pharmacy (GPhC Registration: 9011661)

Church Pharmacy (GPhC Registration: 1121625)

​

© 2025 website owned and operated by Slim Transformation®

bottom of page